Literature DB >> 3502681

Biphasic effects of epidermal growth factor on bone nodule formation by isolated rat calvaria cells in vitro.

M E Antosz1, C G Bellows, J E Aubin.   

Abstract

Osteoblast-like cells isolated from fetal rat calvaria (RC) form three-dimensional nodules in vitro having the morphological and immunohistochemical characteristics of bone. When administered continually over 21 days of culture, EGF caused a dose-related inhibition of nodule formation, as well as a reduction in the proportion of mineralized nodules, at concentrations between 10(-12) to 10(-7) M. The same conditions caused an increase in both cell proliferation and saturation density in the cultures, suggesting that decreased nodule formation was not the result of general cell toxicity. Inhibitory concentrations of EGF caused a reversible alteration in cell shape, although changes in protein synthesis were not detectable. Indomethacin (5 X 10(-7) M) did not affect either nodule formation or its inhibition by EGF. When cultures were pretreated for various time periods with 10(-8) M EGF followed by its removal and continued culture in supplemented medium for 21 days, the number of bone nodules formed with brief exposures to EGF (4 hr up to 48 hr) was increased compared to the numbers formed in supplemented medium alone, whereas exposures to EGF of 4 days or longer decreased the number of nodules formed. These data indicate that EGF can either increase or decrease the osteogenic potential of RC cells in vitro depending on the duration of exposure to the factor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3502681     DOI: 10.1002/jbmr.5650020505

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  8 in total

1.  Epidermal growth factor (EGF) promotes bone healing in surgically induced osteonecrosis of the femoral head (ONFH).

Authors:  Ozgur Basal; Tolga Atay; İbrahim Metin Ciris; Yakup Barbaros Baykal
Journal:  Bosn J Basic Med Sci       Date:  2018-11-07       Impact factor: 3.363

2.  The reduced osteogenic potential of Nf1-deficient osteoprogenitors is EGFR-independent.

Authors:  S E Tahaei; G Couasnay; Y Ma; N Paria; J Gu; B F Lemoine; X Wang; J J Rios; F Elefteriou
Journal:  Bone       Date:  2017-10-12       Impact factor: 4.398

3.  Retinoids modulate the effect of PTH and calcitriol on EGF receptor expression in UMR 106-01 cells.

Authors:  E A González; K J Martin
Journal:  Calcif Tissue Int       Date:  1996-06       Impact factor: 4.333

4.  Betacellulin inhibits osteogenic differentiation and stimulates proliferation through HIF-1alpha.

Authors:  Damian C Genetos; Rameshwar R Rao; Martin A Vidal
Journal:  Cell Tissue Res       Date:  2010-02-18       Impact factor: 5.249

5.  Epidermal growth factor induces Egr-1 messenger RNA and protein in mouse osteoblastic cells.

Authors:  M A Fang; G M Noguchi; S McDougall
Journal:  Calcif Tissue Int       Date:  1995-12       Impact factor: 4.333

6.  Effects of genistein, tyrphostin, and pertussis toxin on EGF-induced mitogenesis in primary culture and clonal osteoblastic cells.

Authors:  E B Stephan; R Dziak
Journal:  Calcif Tissue Int       Date:  1994-05       Impact factor: 4.333

7.  Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone.

Authors:  A E Grigoriadis; J N Heersche; J E Aubin
Journal:  J Cell Biol       Date:  1988-06       Impact factor: 10.539

8.  Cross-talk between EGF and BMP9 signalling pathways regulates the osteogenic differentiation of mesenchymal stem cells.

Authors:  Xing Liu; Jiaqiang Qin; Qing Luo; Yang Bi; Gaohui Zhu; Wei Jiang; Stephanie H Kim; Mi Li; Yuxi Su; Guoxin Nan; Jing Cui; Wenwen Zhang; Ruidong Li; Xiang Chen; Yuhan Kong; Jiye Zhang; Jinhua Wang; Mary Rose Rogers; Hongyu Zhang; Wei Shui; Chen Zhao; Ning Wang; Xi Liang; Ningning Wu; Yunfeng He; Hue H Luu; Rex C Haydon; Lewis L Shi; Tingyu Li; Tong-Chuan He; Ming Li
Journal:  J Cell Mol Med       Date:  2013-07-11       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.